Ionis Pharmaceuticals - US biotech company impresses with strong pipeline!
Reading Time: 1 minute
Business Driver: The US biotech company Ionis Pharmaceuticals (IONS) specializes in the development of drugs and therapies for the treatment of rare genetic disorders. With Spiranza (spinal muscular atrophy (SMA)), Tegsedi (hereditary transthyretin amyloidosis (hATTR)), and Waylivra (Familial Chylomicronemia Syndrome (FCS)), Ionis has several promising drugs in the advanced stages of clinical development. Here, hopes are particularly placed on Olezarsen, a drug that has proven to be promising in the treatment of Familial Chylomicronemia Syndrome,...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
